Augmented urokinase receptor expression in atheroma

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 1, 1995, Pages 37-43

  Noda Heiny, Hiroko ^a   Daugherty, Alan ^a   Sobel, Burton E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherogenesis; cell migration; plasminogen activators; restenosis

Indexed keywords

UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER;

EID: 0028909377     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.1.37     Document Type: Article

References (44)

1. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
2. Moller LB. Structure and function of the urokinase receptor. Blood Coagul Fibrinolysis. 1993;4:293-303.
3. Ploug M, Behrendt N, Lober D, Dano K. Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator. Semin Thromb Hemost. 1991;17:183-193.
4. Blasi F. Fibrinolytic tests and extravascular proteolysis: urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Fibrinolysis. 1993;7:17-18.
5. Fazioli F, Blasi F. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? Trends Pharmacol Sci. 1994;15:25-29.
6. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 1990;9:467-474.
7. r receptor protein for urokinase-type plasminogen activator. J Biol Chem. 1988;263:2358-2363.
8. 2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. J Biol Chem. 1993;268:17539-17546.
9. Myohanen HT, Stephens RW, Hedman K, Tapiovaara H, Ronne E, Hoyer-Hansen G, et al. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J Histochem Cytochem. 1993;41:1291-1301.
10. Franco P, Mastronicola R, De Cesare D, Molli ML, Wun T-C, Verde P, et al. Separation and characterization of nonphosphorylated and serine-phosphorylated urokinase. J Biol Chem. 1992;267:19369-19372.
11. Del Rosso M, Fibbi G, Dini G, Grappone C, Pucci M. Modulation of surface-associated urokinase in different cell lines: evidence for urokinase interiorization and degradation. Semin Thromb Hemost. 1991;17:262-267.
12. Cubellis MV, Wun T-C, Blasi F. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 1990;9:1079-1085.
13. Jensen PH, Christensen EI, Ebbesen P, Gliemann J, Andreasen PA. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. Cell Regulation. 1990;1:1043-1056.
14. Herz J, Clouthier DE, Hammer RE. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell. 1992;71:411-421.
15. Testa JE, Quigley JP. The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev. 1990;9:353-367.
16. Blasi F. Surface receptors for urokinase plasminogen activator. Fibrinolysis. 1988;2:73-84.
17. Blasi F, Behrendt N, Cubellis MV, Ellis V, Lund LR, Masucci MT, et al. The urokinase receptor and regulation of cell surface plasminogen activation. Cell Differentiation and Development. 1990; 32:247-254.
18. Estreicher A, Mühlhauser J, Carpentier J-L, Orci L, Vassalli J-D. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 1990;111:783-792.
19. Skriver L, Larsson L-I, Kielberg V, Nielsen LS, Andresen PB, Kristensen P, Dano K. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J Cell Biol. 1984;99:752-757.
20. Zini J-M, Murray SC, Graham CH, Lala PK, Kariko K, Barnathan ES, et al. Characterization of urokinase receptor expression by human placental trophoblasts. Blood. 1992;79:2917-2929.
21. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A. 1993;90:5021-5025.
22. Ossowski L, Reich E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell. 1983;35:611-619.
23. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 1993;53:4143-4147.
24. Pyke C, Graem N, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Brunner N, Danno K. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res. 1993;53:1911-1915.
25. Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, et al. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res. 1993;53:3198-3206.
26. Myra-y-Lopez R, Reich E, Ossowski L. Modulation of plasminogen activator in rodent mammary tumors by hormones and other effectors. Cancer Res. 1983;43:5467-5477.
27. Barnathan ES, Kuo A, Kariko K, Rosenfeld L, Murray SC, Behrend N, et al. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. Blood. 1990;76:1795-1806.
28. Pepper MS, Sappino A-P, Stocklin R, Montesano R, Orci L, Vassalli J-D. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol. 1993;122:673-684.
29. Reuning U, Bang NU. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Arterioscler Thromb. 1992;12:1161-1170.
30. Noda-Heiny H, Fujii S, Sobel BE. Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Circ Res. 1993;72:36-43.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
32. Rosenfeld ME, Tsukada T, Gown AM, Ross R. Fatty streak initiation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:9-23.
33. Rosenfeld ME, Tsukada T, Chait A, Bierman EL, Gown AM, Ross R. Fatty streak expansion and maturation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:24-34.
34. Kirchheimer JC, Binder BR. Function of receptor-bound urokinase. Semin Thromb Hemost. 1991;17:246-250.
35. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993;13:1218-1226.
36. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
37. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986;83:7311-7315.
38. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Vergilio J, Nicholson AC. Macrophage and foam cell release of matrix-bound growth factors: role of plasminogen activator. J Biol Chem. 1993;268:11951-11958.
39. Haddock RC, Spell ML, Baker CD III, Grammer JR, Parks JM, Speidel M, et al. Urokinase binding and receptor identification in cultured endothelial cells. J Biol Chem. 1991;266:21466-21473.
40. Moller LB, Pollanen J, Ronne E, Pedersen N, Blasi F. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. J Biol Chem. 1993;268:11152-11159.
41. Solberg H, Lober D, Eriksen J, Ploug M, Ronne E, Behrendt N, Dano K, Hoyer-Hansen G. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Eur J Biochem. 1992;205:451-458.
42. 2-terminal amino acid sequence and glycosylation variants. J Biol Chem. 1990;265: 6453-6460.
43. Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol. 1990;137:7-12.
44. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 1994;368:419-424.